MedPath

Comparison of the AMBU Aura-i and LMA Supreme supraglottic airway devices in spontaneously breathing anaesthetised patients

Phase 4
Completed
Conditions
Performance of airway device
Spontaneously breathing anaesthetised females undergoing minor gynaeocological procedures
Anaesthesiology - Anaesthetics
Registration Number
ACTRN12614000032651
Lead Sponsor
Dr Wendy H.L. Teoh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

One hundred ASA I- II patients scheduled for elective minor gynaecological and breast procedures in our women's hospital

Exclusion Criteria

ASA physical status III or IV; BMI equal to and greater than 40 kg/m2, those with predicted difficult airway; high risk of regurgitation or aspiration; and respiratory tract pathology (including preoperative sore throat).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The time taken to establish effective ventilation.This is the interval from when the Ambu Aura-i or LMA Supreme entered the mouth to the first capnograph trace.[After the Ambu Aura-i or LMA Supreme airway device has been inserted into the participant's mouth.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath